Status:
WITHDRAWN
Use of Alfuzosin in Stone Treatment With ESWL
Lead Sponsor:
Singapore General Hospital
Collaborating Sponsors:
Sanofi
Conditions:
Urinary Calculi
Eligibility:
All Genders
21+ years
Phase:
PHASE3
Brief Summary
Urinary tract stones may form in the kidneys or along the ureteric tracts and when left untreated, may result in complications such as pain, bleeding, infection and obstruction. ESWL (extra-corporeal ...
Detailed Description
Urinary tract stones may form in the kidneys or along the ureteric tracts and when left untreated, may result in complications such as pain, bleeding, infection and obstruction. ESWL (extra-corporeal ...
Eligibility Criteria
Inclusion
- All adult patients referred to our centre for ESWL treatment of renal or ureteric stones who give their informed consent.
Exclusion
- Documented allergy or severe side effects to opioids/ NSAIDs/ Alfuzosin Severe hydronephrosis (on ultrasound or IVU) Radiolucent stones Urinary tract infections Previous pyeloureteral surgery Lower pole stones DJ stents in situ for stones Known renal/hepatic impairment or coagulopathy Pregnant Severe skeletal disease
Key Trial Info
Start Date :
October 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00388271
Start Date
October 1 2006
End Date
December 1 2007
Last Update
February 10 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Urology Centre
Singapore, Singapore